KITE
Kite Pharma Inc
Clinical-stage biopharmaceutical company developing cancer immunotherapies
CUSIP: 49803L109HealthcareUS1 holder
Total Value
$103.75M
Total Shares
2.26M
Net Share Change
+52.6K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$103.75M2.26M shares
ADD+52.6K(+2.4%)